03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *
Valcyte* : | |
Type | Medicine Non Marketed |
Originator | B |
Agent | Omnipharma |
Distributor | Omnipharma |
Laboratory | Roche |
Responsible Party | Patheon Inc |
Origin | Canada |
Manufacturer | Patheon Inc |
Origin | Canada |
ATC | J05AB14 |
Valcyte* :
Valcyte* :
Valcyte* :
Valcyte* :
Valcyte* :
Hazard Level |
---|
◼ Major |
◼ Moderate |
◼ Minor |
◼ Safe |
Valcyte* :
Frequency | Percentage |
---|---|
Very Common | ≥ 1/10 |
Common | ≥ 1/100 - < 1/10 |
Uncommon | ≥ 1/1,000 - < 1/100 |
Rare | ≥ 1/10,000 - < 1/1,000 |
Very Rare | < 1/10,000 |
Unknown | Cannot be Estimated |
Effect | Frequency |
---|---|
Abdominal distension | Common |
Abdominal pain | Very Common |
Abdominal pain upper | Common |
Acne | Common |
Agitation | Uncommon |
Anaemia | Very Common |
Anaphylaxis | Not known |
Anorexia | Common |
Aplastic anemia | Rare |
Arthralgia (Pain joint) (Joint ache) | Common |
Asthenia | Common |
Back pain | Very Common |
Blood creatinine increased | Very Common |
Bone marrow depression | Uncommon |
Bronchitis | Common |
Cachexia | Common |
Cephalea | Very Common |
Confusion | Uncommon |
Constipation | Very Common |
Convulsion | Uncommon |
Cough | Very Common |
Creatinine renal clearance decreased | Common |
Decreased appetite | Common |
Dehydration | Common |
Depression | Common |
Dermatitis | Very Common |
Diarrhoea (Diarrhea) | Very Common |
Drug hypersensitivity | Uncommon |
Dyspepsia | Very Common |
Dyspnoea (dyspnea) | Very Common |
Dysuria (Micturition painful) | Common |
Fatigue | Very Common |
Fertility male decreased | Not known |
Hallucination | Uncommon |
Hepatic function disorder | Common |
Hyperglycaemia | Common |
Hyperkalaemia | Very Common |
Hypertension | Very Common |
Hypocalcaemia | Common |
Hypokalaemia | Common |
Hypomagnesaemia | Common |
Hypophosphataemia | Common |
Hypotension | Common |
Influenza | Common |
Insomnia | Very Common |
Leg oedema | Very Common |
Leucopenia (Leukopenia) | Very Common |
Lightheadedness | Very Common |
Macular oedema | Common |
Muscle cramps | Common |
Nasopharyngitis | Very Common |
Nausea | Very Common |
Neuropathy peripheral | Common |
Neutropenia | Common |
Night sweats | Common |
Oedema | Very Common |
Oedema peripheral | Common |
Oral candidiasis | Very Common |
Pain | Common |
Pain in extremity (Pain in limb) | Common |
Pancytopenia | Common |
Paraesthesia (paresthesia) | Common |
Pharyngitis | Very Common |
Phlebitis | Common |
Platelet count decreased (Thrombocyte count decreased) | Common |
Pleural effusion | Common |
Pneumocystis carinii pneumonia | Common |
Pneumonia | Common |
Postoperative complications | Very Common |
Postoperative pain | Very Common |
Productive cough | Common |
Prothrombin level decreased | Very rare |
Pruritus | Common |
Psychosis | Not known |
Pyrexia | Very Common |
Renal impairment | Common |
Retinal detachment | Common |
Rhinorrhoea | Common |
Sinusitis | Common |
Thrombocytopenic hemorrhage | Common |
Thrombophlebitis | Common |
Transplant rejection | Very Common |
Tremor | Very Common |
Upper respiratory tract infection | Common |
Urinary tract infection | Very Common |
Vision blurred | Common |
Vomiting | Very Common |
Weight decreased (Weight loss) | Common |
Wound dehiscence | Common |
Wound infection | Very Common |
Valcyte* :
NB : Products With Same Indication |
Different Units By MoH Code
Valcyte* MoH 5053 :
Form | Tablet, Film-Coated |
Packaging | Bottle (HDPE) (high density polyethylene) |
Package Size | Box of 60 |
Strength | 450mg |
NSSF | ✘ |
Quarantine | ✘ |
Reg. Number | 241116/06 |
Submission date | 01/01/2006 |
Registration Year | 2006 |
Archived Date | 2014 |
Price Comparison
● Country: | Germany | |
● Package Size: | 60 | |
● Public Price: | 2182.68 EUR | ( 211,449,307.68 LBP ) |
● Pack size unit used: | 60 | |
● Cost/Unit: | 36,378 EUR | ( 3,487,536.00 LBP ) |
● Pricing Date: | 24/10/2020 | |
● Type: | Medicine Authorised |
You have to register to view this info
Drop File